Sequenom to Present at the Global Hunter Securities Healthcare Conference |
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
SEQUENOM, Inc
3595 John Hopkins Court
San Diego, CA, 92121-1331
USA
Press release date: August 11, 2010
SAN DIEGO, Aug. 11 -- Sequenom, Inc. (NASDAQ:SQNM) today announced that Harry F. Hixson, PhD, chairman and CEO, will present an overview of the company at the Inaugural Global Hunter Securities Healthcare Conference at the Island Hotel in Newport Beach, CA.
Dr. Hixson is scheduled to present on Tuesday, August 17, 2010 at 11:00am PT.
A live webcast and 30-day archive of these presentations will be available at http://ir.sequenom.com/.
About Sequenom
Sequenom, Inc. (NASDAQ:SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. The company was founded in 1994 and is headquartered in San Diego, California. Sequenom maintains a Web site at http://www.sequenom.com/ to which Sequenom regularly posts copies of its press releases as well as additional information about Sequenom. Interested persons can subscribe on the Sequenom Web site to email alerts or RSS feeds that are sent automatically when Sequenom issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the Web site.
Source: Sequenom, Inc.
CONTACT: Ian Clements, PhD, Sr. Director, IR & Corporate Communications of Sequenom, Inc., +1-858-202-9000; or Media Relations, Dan Budwick of Pure Communications, +1-973-271-6085, for Sequenom, Inc.
Web Site: http://www.sequenom.com/
|
|
|
|
|
|
|
|
|
|
|
| 
